✦ LIBER ✦

Pharmacokinetics of the nonnucleoside reverse transcriptase inhibitor efavirenz among HIV-infected Ugandans

✍ Scribed by S Nanzigu; J Eriksen; F Makumbi; S Lanke; M Mahindi; R Kiguba; O Beck; Q Ma; GD Morse; LL Gustafsson; P Waako

Book ID: 115235869
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 234 KB
Volume: 13
Category: Article
ISSN: 1464-2662
DOI: 10.1111/j.1468-1293.2011.00952.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prophylaxis against HIV-1 infection in c

Prophylaxis against HIV-1 infection in chimpanzees by nevirapine, a nonnucleoside inhibitor of reverse transcriptase

✍ Grob, Peter M.; Cao, Yunzhen; Muchmore, Elizabeth; Ho, David D.; Norris, Steve; 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 618 KB

Low prevalence of insulin resistance amo

Low prevalence of insulin resistance among HIV-infected children receiving nonnucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in Thailand

✍ B Lee; L Aurpibul; V Sirisanthana; A Mangklabruks; T Sirisanthana; T Puthanakit 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

Etravirine for HIV-I: Addressing the Lim

Etravirine for HIV-I: Addressing the Limitations of the Nonnucleoside Reverse Transcriptase Inhibitor Class

✍ Grennan, T.; Walmsley, S. 📂 Article 📅 2009 🏛 SAGE Publications 🌐 English ⚖ 202 KB

Treatment of HIV-infected patients with

Treatment of HIV-infected patients with a combination of efavirenz, nevirapine and nucleoside reverse transcriptase inhibitors

✍ JA Arranz-Caso; M Gorgolas; V Estrada; JD García-Diaz 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB

Conformational analysis of the HIV-1 vir

Conformational analysis of the HIV-1 virus reverse transcriptase nonnucleoside inhibitors: TIBO and nevirapine

✍ Odonírio Abrahão-Júnior; Paulo G. B. D. Nascimento; Sérgio E. Galembeck 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 244 KB

## Abstract TIBO (Tetrahydro‐imidazo[4,5,1‐jk][1,4]‐benzodiazepin‐2‐one) and nevirapine (11‐cyclopropyl‐5,11‐dihydro‐4‐methyl‐6H‐dipyrido[3,2‐b:2′,3′‐e][1,4]diazepin‐6‐one) are models for two classes of nonnucleoside inhibitors of the HIV‐1 virus reverse transcriptase (NNRTI). This work presents th

Triple nucleoside reverse transcriptase

Triple nucleoside reverse transcriptase inhibitor- vs. nonnucleoside reverse transcriptase inhibitor-containing regimens as first-line therapy: efficacy and durability in a prospective cohort of French HIV-infected patients

✍ L Cuzin; P Pugliese; F Bugnon; C Delpierre; E Cua; E Billaud; P Massip; F Raffi; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB